About
Deciphera Pharmaceuticals develops targeted cancer therapies by designing switch-control kinase inhibitors to address tumor growth and drug resistance.
Explore Deciphera Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.